Sectoral Asset Management Inc Castle Biosciences Inc Transaction History

Sectoral Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$43.6 - $73.05 $806,600 - $1.35 Million	-18,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $4.81 Million - $6.5 Million	-125,000 Reduced 87.11%	18,500 $952,000
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $3.91 Million - $6.17 Million	143,500 New	143,500 $5.41 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.